Gene · 23521
Papers2,970
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,970
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Serum/Glucocorticoid-Regulated Kinase 1 Is Targeted by miR-19a in CD4+ T Cells. | Cells | 2022 | 36611927 | PubTator, text mining | PubMed |
| Inferencing Bulk Tumor and Single-Cell Multi-Omics Regulatory Networks for Discovery of Biomarkers and Therapeutic Targets. | Cells | 2022 | 36611894 | PubTator, text mining | PubMed |
| Exosomes Released by Influenza-Virus-Infected Cells Carry Factors Capable of Suppressing Immune Defense Genes in Naïve Cells. | Viruses | 2022 | 36560694 | PubTator, text mining | PubMed |
| Butyrate Lowers Cellular Cholesterol through HDAC Inhibition and Impaired SREBP-2 Signalling. | Int J Mol Sci | 2022 | 36555149 | PubTator, text mining | PubMed |
| Nicotine and Cotinine Induce Neutrophil Extracellular Trap Formation-Potential Risk for Impaired Wound Healing in Smokers. | Antioxidants (Basel) | 2022 | 36552632 | PubTator, text mining | PubMed |
| Generation of Endogenous Promoter-Driven Luciferase Reporter System Using CRISPR/Cas9 for Investigating Transcriptional Regulation of the Core Clock Gene BMAL1. | Biomedicines | 2022 | 36551864 | PubTator, text mining | PubMed |
| Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammation. | JCI Insight | 2022 | 36546480 | PubTator, text mining | PubMed |
| Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and Naturally Occurring Compounds, Part II. | Ann Clin Case Rep | 2022 | 36540866 | PubTator, text mining | PubMed |
| Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC-derived multipotent cells. | Clin Transl Med | 2022 | 36536500 | PubTator, text mining | PubMed |
| Putative critical quality attribute matrix identifies mesenchymal stromal cells with potent immunomodulatory and angiogenic "fitness" ranges in response to culture process parameters. | Front Immunol | 2022 | 36532069 | PubTator, text mining | PubMed |
| Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity. | Mil Med Res | 2022 | 36529792 | PubTator, text mining | PubMed |
| Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19. | Nat Commun | 2022 | 36526616 | PubTator, text mining | PubMed |
| A signal recognition particle-related joint model of LASSO regression, SVM-RFE and artificial neural network for the diagnosis of systemic sclerosis-associated pulmonary hypertension. | Front Genet | 2022 | 36518216 | PubTator, text mining | PubMed |
| Single nuclei profiling identifies cell specific markers of skeletal muscle aging, frailty, and senescence. | Aging (Albany NY) | 2022 | 36516485 | PubTator, text mining | PubMed |
| The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis. | Mol Ther Nucleic Acids | 2022 | 36514354 | PubTator, text mining | PubMed |
| Meta-Analysis of RNA-Seq Datasets Identifies Novel Players in Glioblastoma. | Cancers (Basel) | 2022 | 36497269 | PubTator, text mining | PubMed |
| The POLR3G Subunit of Human RNA Polymerase III Regulates Tumorigenesis and Metastasis in Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 36497214 | PubTator, text mining | PubMed |
| Mutational analysis of ribosomal proteins in a cohort of pediatric patients with T-cell acute lymphoblastic leukemia reveals Q123R, a novel mutation in RPL10. | Front Genet | 2022 | 36482893 | PubTator, text mining | PubMed |
| RAD18 opposes transcription-associated genome instability through FANCD2 recruitment. | PLoS Genet | 2022 | 36480547 | PubTator, text mining | PubMed |
| NRP1 inhibition modulates radiosensitivity of medulloblastoma by targeting cancer stem cells. | Cancer Cell Int | 2022 | 36457009 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23521/papers?page=16